SUMM.L Share News (SUMM)

22 Oct 2012

Summit, a UK drug discovery company, said it had been awarded four million pounds to support clinical development of a new C. difficult antibiotic Th...

10 Oct 2012

Shares in drug developer Summit Corporation rocketed on Wednesday after it announced positive results in tests for its new Duchenne Muscular Dystrophy...

11 Sep 2012

UK drug discovery company Summit has signed a technology licensing agreement with US pharmaceuticals colossus, Bristol-Myers Squibb. The US firm will...

11 Sep 2012

Shares in Summit Corporation, an Oxford based drug developer, soared 20 per cent on Tuesday after it announced it has entered a technology licence agr...

5 Apr 2012

Lord Wolfson of Aspley Guise, Chief Executive of High Street retailer Next, has made his first sale since March 2007 in a move which triggered a wides...

4 Apr 2012

It's all go at Oxford based drug developer Summit Corporation as the firm announces a five million pound share placing, appoints a new Chief Executive...

6 Mar 2012

Summit Corporation, a drug research group, has reported positive data from in vivo studies in its drug discovery programme targeting Alzheimer's disea...

30 Mar 2011

Drug discovery company Summit Corporation is in discussions with potential partners for the Seglin platform. The Seglin platform enables the identif...